Philip Morgan

InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California.

Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA.

IntraPace, Inc. develops systems for the treatment of obesity. These also track patient activity levels, providing an overview of food consumption and exercise trends. The company was founded in 2001 and is headquartered in San Jose, CA.

Entrack, Inc. specializes in the development of novel treatment solutions for the diagnosis and treatment of gastrointestinal diseases. The firm operates as a medical technology venture company, with focus on the development of gastric stimulators for the treatment of obesity-related conditions and disorders. The company was founded in 2001 and is headquartered in San Jose, CA.

EGeen International Corp. provides drugs and medical services. It focuses on therapeutics, such as anti-inflammatory, anti-infectives, CVD, dermatology, metabolism and endocrine, CNS and neurology, oncology, pulmonary, and vaccines. The firm specializes in clinical trials of biologics, therapeutic vaccines, drug or device combinations, and various formulations of small molecule drugs. The company was founded by Kalev Kask in 2001 and is headquartered in Mountain View, CA.

The Angels' Forum Management Co LLC (The Angels' Forum) is a venture capital firm founded in 1997 by Carol Sands, Craig Sirnio and Alejandro Estrada. The firm is headquartered in Mountain View, California.

Body Media, Inc. develops, markets, and sells body monitoring products and applications. It offers wearable body monitors that record and transmit physiological data utilized in observing health and wellness conditions particularly weight management. The company was founded by John Stivoric in 1999 and is headquartered in Pittsburgh, PA.

Neurolink, Inc. provides devices for the treatment of epilepsy. It has developed a drug-device combination therapy for the treatment of epilepsy. The therapy delivers a powerful pharmacologic agent to the brain in small quantities through the implanted device. The company was founded in 2007 and is headquartered in San Antonio, TX.

Python Medical, Inc. develops novel treatments and devices for gastrointestinal disorders. The company was founded on June 6, 2002 and is headquartered in San Jose, CA.

Spinal Modulation, Inc. engages in the development of spinal cord stimulator systems for the treatment of chronic intractable pain. It offers Spinal Modulation Axium neurostimulator system, which is an intraspinal neuromodulation therapy that stimulates the dorsal root ganglion to provide pain management. The company was founded by Mir A. Imran and Daniel H. Kim in 2004 and is headquartered in St. Paul, MN.

L-3 Communications Safeview, Inc. provides security software solutions. It develops security systems that detect weapons, explosives, contrabands, products, and other objects of concern such as plastics, ceramics and metals. The company was founded in 2002 and is headquartered in Santa Clara, CA.

Intact Medical Corp. develops and distributes minimally invasive devices for the excision of breast tissue for diagnostic and therapeutic applications. The company founded by Scott P. Huntley and Philip E. Eggers in 1998 and is headquartered in Naples, FL.

Modulus, Inc. manufactures and supplies microelectronics. It designs microelectronics for class II and class III medical devices.The company was founded by Marv Akerman in 1972 and is headquartered in San Jose, CA.

InCube Ventures LP seeks investment opportunities in life sciences companies located in the United States. The fund targets companies operating in the fields of medical and healthcare technologies. It provides financing for early, mid and late stage capital requirements.

Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA.

Aequus BioPharma was formed in May 2007 as a majority-owned subsidiary of Cell Therapeutics, Inc. to discover, develop, and market biotherapeutics based upon the proprietary Genetic Polymer technology platform invented at CTI. Its technology addresses many of the traditional problems encountered during the development and commercialization of protein-based biopharmaceuticals. Aequus and CTI are collaborating on the development of AQB-101, a follow-on protein product or biosimilar based upon granulocyte-colony stimulating factor (G-CSF) coupled to a Genetic Polymer carrier domain. The company believe that AQB-101 provides an elegantly simple solution to the plasma half-life and bioavailability issues that have been observed with the original formulations of G-CSF-based biomedicines and which have been addressed by others using traditional chemical modification approaches in their G-CSF-based biosimilars.

KitoTech Medical, Inc. operates as a medical device company which develops medical products based on its proprietary micro staple technology platform. It specializes in wound closure, patient care, emergency laceration, surgery, skin closure device, and biotechnology. The company was founded by Ronald J. Berenson and Marco Rolandi in 2013 and is headquartered in Seattle, WA.

Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA.

DMD Therapeutics, Inc. develops novel therapeutics for DMD and other muscular dystrophies. The company was founded by Carlo Rago and Ronald Berenson in 2016 and is headquartered in Seattle, WA.

Part of Interpublic Group of Cos., Inc., Jstreetdata.com, Inc. is an American company that provides streamlined custom and syndicated on-line medical market research, enabling quick data-driven decisions in the life sciences and medical industries. The company is based in Washington. Jstreetdata.com was acquired by NFO Worldwide, Inc. on September 04, 2002.

Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA.

ADERIS Pharmaceuticals, Inc. develops and commercializes drugs and pharmaceuticals. It engages in small molecule drug development to treat central nervous system, cardiovascular, and inflammatory disorders. The company was founded by Donald McAfee, Noel Cusack, Gevork I. Minaskanian, and Peter Savasand in 1994 and is headquartered in Hopkinton, MA.

Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA.